Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Perrigo Co Plc (PRGO) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Perrigo Co Plc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1585364.
Total stock buying since 2015: $39,050,814.
Total stock sales since 2015: $25,496,495.
Total stock option exercises since 2015: $60,478,249.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 0 | $0 | 0 | $0 | 191,486 | $2,084,168 |
| 2025 | 26,578 | $556,870 | 7,800 | $214,032 | 187,430 | $4,946,705 |
| 2024 | 20,906 | $553,771 | 74,535 | $2,089,022 | 166,664 | $4,822,675 |
| 2023 | 41,490 | $1,314,519 | 214,869 | $7,686,349 | 194,964 | $7,015,628 |
| 2022 | 0 | $0 | 33,066 | $1,214,496 | 172,736 | $6,506,164 |
| 2021 | 64,968 | $2,432,603 | 2,662 | $109,767 | 123,099 | $4,955,734 |
| 2020 | 11,465 | $545,920 | 4,595 | $238,943 | 104,443 | $5,542,792 |
| 2019 | 4,000 | $187,892 | 7,600 | $387,546 | 97,675 | $4,766,460 |
| 2018 | 443,983 | $33,177,304 | 0 | $0 | 54,995 | $3,947,332 |
| 2017 | 700 | $60,060 | 9,907 | $843,613 | 30,445 | $2,345,890 |
| 2016 | 2,500 | $221,875 | 52,667 | $6,482,088 | 72,072 | $4,921,395 |
| 2015 | 0 | $0 | 36,046 | $6,230,639 | 66,728 | $8,623,306 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-04-05 | Silcock Raymond (EVP, Chief Financial Officer) | Option Ex | 3,963 | 36.27 | 143,738 |
| 2022-03-14 | Farrington Thomas (EVP and CIO) | Sale | 26,744 | 37.18 | 994,315 |
| 2022-03-07 | Janish Ronald Craig (EVP, Gbl Ops & SC & CTO) | Sale | 3,954 | 36.73 | 145,234 |
| 2022-03-04 | Willis Robert (EVP & CHRO) | Option Ex | 5,012 | 37.23 | 186,596 |
| 2022-03-04 | Andersen Svend (EVP & President CHCI) | Option Ex | 8,911 | 37.23 | 331,756 |
| 2022-03-04 | Janish Ronald Craig (EVP, Gbl Ops & SC & CTO) | Option Ex | 5,410 | 37.23 | 201,414 |
| 2022-03-04 | Quinn Grainne (EVP, Chief Medical Officer) | Option Ex | 3,862 | 37.23 | 143,782 |
| 2022-03-04 | Dillard James E Iii (EVP & President CSCA) | Option Ex | 7,002 | 37.23 | 260,684 |
| 2022-03-04 | Ashford Orlando D | Option Ex | 2,984 | 37.23 | 111,094 |
| 2022-03-04 | Farrington Thomas (EVP and CIO) | Option Ex | 4,424 | 37.23 | 164,705 |
| 2022-03-04 | Kingma Todd W (Executive VP, General Counsel) | Option Ex | 8,911 | 37.23 | 331,756 |
| 2022-03-04 | Kessler Murray S (CEO) | Option Ex | 49,328 | 37.23 | 1,836,481 |
| 2022-03-04 | Silcock Raymond (EVP, Chief Financial Officer) | Option Ex | 8,502 | 37.23 | 316,529 |
| 2022-02-07 | Dillard James E Iii (EVP & President CSCA) | Option Ex | 4,297 | 36.95 | 158,774 |
| 2021-12-17 | Kingma Todd W (Executive VP, General Counsel) | Buy | 3,000 | 37.55 | 112,647 |
| 2021-12-16 | Parker Geoffrey M. | Buy | 5,000 | 36.85 | 184,270 |
| 2021-12-16 | Alford Bradley A | Buy | 13,000 | 36.88 | 479,414 |
| 2021-12-06 | Andersen Svend (EVP & President CHCI) | Buy | 3,655 | 37.09 | 135,582 |
| 2021-12-03 | Silcock Raymond (EVP, Chief Financial Officer) | Buy | 27,500 | 36.03 | 990,935 |
| 2021-12-02 | Classon Rolf A | Buy | 2,800 | 35.67 | 99,873 |
| 2021-08-12 | Doyle Katherine C. | Option Ex | 5,637 | 41.28 | 232,695 |
| 2021-05-07 | Samuels Theodore R. Ii | Option Ex | 5,804 | 42.96 | 249,339 |
| 2021-05-07 | O'connor Donal | Option Ex | 5,804 | 42.96 | 249,339 |
| 2021-05-07 | Karaboutis Adriana | Option Ex | 5,804 | 42.96 | 249,339 |
| 2021-05-07 | Parker Geoffrey M. | Option Ex | 5,804 | 42.96 | 249,339 |
| 2021-05-07 | Alford Bradley A | Option Ex | 5,804 | 42.96 | 249,339 |
| 2021-05-07 | Kindler Jeffrey B | Option Ex | 5,804 | 42.96 | 249,339 |
| 2021-05-07 | Classon Rolf A | Option Ex | 7,255 | 42.96 | 311,674 |
| 2021-04-05 | Silcock Raymond (EVP, Chief Financial Officer) | Option Ex | 3,964 | 40.39 | 160,105 |
| 2021-03-17 | Parker Geoffrey M. | Buy | 2,500 | 41.29 | 103,217 |
| 2021-03-10 | Janish Ronald Craig (EVP, Gbl Ops & SC & CTO) | Sale | 2,662 | 41.23 | 109,767 |
| 2021-03-08 | Willis Robert (EVP & CHRO) | Option Ex | 697 | 41.82 | 29,148 |
| 2021-03-05 | Willis Robert (EVP & CHRO) | Option Ex | 2,083 | 41.04 | 85,486 |
| 2021-03-05 | Andersen Svend (EVP & President CHCI) | Option Ex | 5,500 | 41.04 | 225,720 |
| 2021-03-05 | Janish Ronald Craig (EVP, Gbl Ops & SC & CTO) | Option Ex | 3,339 | 41.04 | 137,032 |
| 2021-03-05 | Quinn Grainne (EVP, Chief Medical Officer) | Option Ex | 2,279 | 41.04 | 93,530 |
| 2021-03-05 | Dillard James E Iii (EVP, Chief Scientific Officer) | Option Ex | 4,322 | 41.04 | 177,374 |
| 2021-03-05 | Sorota Richard S (EVP & President CSCA) | Option Ex | 2,540 | 41.04 | 104,241 |
| 2021-03-05 | Farrington Thomas (EVP and CIO) | Option Ex | 2,730 | 41.04 | 112,039 |
| 2021-03-05 | Kochan Sharon (EVP & President Rx) | Option Ex | 4,057 | 41.04 | 166,499 |
| 2021-03-05 | Kingma Todd W (Executive VP, General Counsel) | Option Ex | 5,500 | 41.04 | 225,720 |
| 2021-03-05 | Kessler Murray S (CEO) | Option Ex | 30,446 | 41.04 | 1,249,503 |
| 2021-03-05 | Silcock Raymond (EVP, Chief Financial Officer) | Option Ex | 3,629 | 41.04 | 148,934 |
| 2021-02-05 | Dillard James E Iii (EVP, Chief Scientific Officer) | Option Ex | 4,297 | .00 | 0 |
| 2021-01-06 | Sorota Richard S (EVP & President CSCA) | Buy | 7,513 | 43.48 | 326,665 |
| 2020-11-09 | Samuels Theodore R. Ii | Buy | 4,500 | 46.91 | 211,113 |
| 2020-11-09 | Classon Rolf A | Buy | 2,137 | 46.75 | 99,898 |
| 2020-08-14 | Willis Robert (EVP & CHRO) | Option Ex | 581 | 53.40 | 31,025 |
| 2020-08-11 | Andersen Svend (EVP & President CHCI) | Buy | 2,828 | 53.01 | 149,909 |
| 2020-06-29 | Willis Robert (EVP & CHRO) | Option Ex | 270 | 54.56 | 14,731 |
| 2020-06-29 | Janish Ronald Craig (EVP, Global Op. & Supply Chain) | Option Ex | 827 | 54.56 | 45,121 |
| 2020-06-29 | Quinn Grainne (EVP, Chief Medical Officer) | Option Ex | 262 | 54.56 | 14,294 |
| 2020-06-29 | Needham Jeffrey (EVP, President CHC Americas) | Option Ex | 2,322 | 54.56 | 126,688 |
| 2020-06-29 | Farrington Thomas (EVP and CIO) | Option Ex | 1,398 | 54.56 | 76,274 |
| 2020-06-29 | Kochan Sharon (EVP, GM International) | Option Ex | 2,285 | 54.56 | 124,669 |
| 2020-06-29 | Kingma Todd W (Executive VP, General Counsel) | Option Ex | 2,987 | 54.56 | 162,970 |
| 2020-06-05 | Willis Robert (EVP & CHRO) | Option Ex | 606 | 55.61 | 33,699 |
| 2020-05-15 | Mann Erica L | Option Ex | 6,054 | 52.76 | 319,409 |
| 2020-05-15 | Samuels Theodore R. Ii | Option Ex | 6,054 | 52.76 | 319,409 |
| 2020-05-15 | O'connor Donal | Option Ex | 6,054 | 52.76 | 319,409 |
| 2020-05-15 | Karaboutis Adriana | Option Ex | 6,054 | 52.76 | 319,409 |
| 2020-05-15 | Parker Geoffrey M. | Option Ex | 6,054 | 52.76 | 319,409 |
| 2020-05-15 | Alford Bradley A | Option Ex | 6,054 | 52.76 | 319,409 |
| 2020-05-15 | Kindler Jeffrey B | Option Ex | 6,054 | 52.76 | 319,409 |
| 2020-05-15 | Classon Rolf A | Option Ex | 7,568 | 52.76 | 399,287 |
| 2020-05-07 | Janish Ronald Craig (EVP, Global Op. & Supply Chain) | Sale | 2,595 | 51.90 | 134,675 |
| 2020-05-07 | Farrington Thomas (EVP and CIO) | Sale | 2,000 | 52.13 | 104,268 |
| 2020-04-03 | Silcock Raymond (EVP, Chief Financial Officer) | Option Ex | 3,964 | 44.36 | 175,843 |
| 2020-03-13 | Samuels Theodore R. Ii | Buy | 2,000 | 42.50 | 85,000 |
| 2020-03-06 | Willis Robert (EVP & CHRO) | Option Ex | 550 | 53.17 | 29,243 |
| 2020-03-06 | Andersen Svend (EVP & President CHCI) | Option Ex | 2,960 | 53.17 | 157,383 |
| 2020-03-06 | Janish Ronald Craig (EVP, Global Op. & Supply Chain) | Option Ex | 1,797 | 53.17 | 95,546 |
| 2020-03-06 | Quinn Grainne (EVP, Chief Medical Officer) | Option Ex | 1,227 | 53.17 | 65,239 |
| 2020-03-06 | Dillard James E Iii (EVP, Chief Scientific Officer) | Option Ex | 2,326 | 53.17 | 123,673 |
| 2020-03-06 | Needham Jeffrey (EVP, President CHC Americas) | Option Ex | 2,960 | 53.17 | 157,383 |
| 2020-03-06 | Farrington Thomas (EVP and CIO) | Option Ex | 1,470 | 53.17 | 78,159 |
| 2020-03-06 | Kochan Sharon (EVP, GM International) | Option Ex | 2,062 | 53.17 | 109,636 |
| 2020-03-06 | Kingma Todd W (Executive VP, General Counsel) | Option Ex | 2,960 | 53.17 | 157,383 |
| 2020-03-06 | Kessler Murray S (CEO) | Option Ex | 16,385 | 53.17 | 871,190 |
| 2020-02-07 | Dillard James E Iii (EVP, Chief Scientific Officer) | Option Ex | 4,298 | 59.91 | 257,493 |
| 2019-12-31 | Needham Jeffrey (EVP, President CHC Americas) | Option Ex | 6,169 | 51.66 | 318,690 |
| 2019-12-20 | Kingma Todd W (Executive VP, General Counsel) | Sale | 2,300 | 54.91 | 126,292 |
| 2019-11-11 | Quinn Grainne (EVP, Chief Medical Officer) | Sale | 2,050 | 49.08 | 100,614 |
| 2019-11-08 | Janish Ronald Craig (EVP, Global Op. & Supply Chain) | Sale | 2,424 | 49.90 | 120,967 |
| 2019-10-08 | Andersen Svend (EVP & President CHCI) | Option Ex | 7,527 | 51.94 | 390,952 |
| 2019-10-08 | Janish Ronald Craig (EVP, Global Op. & Supply Chain) | Option Ex | 6,791 | 51.94 | 352,724 |
| 2019-10-08 | Quinn Grainne (EVP, Chief Medical Officer) | Option Ex | 5,011 | 51.94 | 260,271 |
| 2019-10-08 | Needham Jeffrey (EVP, President CHC Americas) | Option Ex | 8,242 | 51.94 | 428,089 |
| 2019-10-08 | Farrington Thomas (EVP and CIO) | Option Ex | 6,113 | 51.94 | 317,509 |
| 2019-10-08 | Kochan Sharon (EVP, GM International) | Option Ex | 7,304 | 51.94 | 379,369 |
| 2019-10-08 | Kingma Todd W (Executive VP, General Counsel) | Option Ex | 7,486 | 51.94 | 388,822 |
| 2019-08-22 | Winowiecki Ronald (CFO) | Sale | 826 | 48.03 | 39,673 |
| 2019-08-09 | Samuels Theodore R. Ii | Buy | 4,000 | 46.97 | 187,892 |
| 2019-07-19 | Winowiecki Ronald (CFO) | Option Ex | 2,296 | 51.56 | 118,381 |
| 2019-05-15 | Samuels Theodore R. Ii | Option Ex | 3,971 | 49.55 | 196,763 |
| 2019-05-15 | O'connor Donal | Option Ex | 3,971 | 49.55 | 196,763 |
| 2019-05-15 | Karaboutis Adriana | Option Ex | 3,971 | .00 | 0 |
| 2019-05-15 | Parker Geoffrey M. | Option Ex | 3,971 | 49.55 | 196,763 |
| 2019-05-15 | Alford Bradley A | Option Ex | 3,971 | 49.55 | 196,763 |
| 2019-05-15 | Smith Jeffrey C | Option Ex | 3,971 | 49.55 | 196,763 |
| 2019-05-15 | Kindler Jeffrey B | Option Ex | 3,971 | 49.55 | 196,763 |
| 2019-05-15 | Classon Rolf A | Option Ex | 4,964 | 49.55 | 245,966 |
| 2019-02-26 | Winowiecki Ronald (CFO) | Option Ex | 485 | 48.29 | 23,420 |
| 2019-02-26 | Wesolowski John (EVP, President Rx) | Option Ex | 282 | 48.29 | 13,617 |
| 2019-02-26 | Weninger Paul (EVP, Quality Operations) | Option Ex | 478 | 48.29 | 23,082 |
| 2019-02-26 | Janish Ronald Craig (EVP, Global Op. & Supply Chain) | Option Ex | 804 | 48.29 | 38,825 |
| 2019-02-26 | Quinn Grainne (EVP, Chief Medical Officer) | Option Ex | 254 | 48.29 | 12,265 |
| 2019-02-26 | Needham Jeffrey (EVP, President CHC Americas) | Option Ex | 1,346 | 48.29 | 64,998 |
| 2019-02-26 | Farrington Thomas (EVP and CIO) | Option Ex | 1,076 | 48.29 | 51,960 |
| 2019-02-26 | Kochan Sharon (EVP, GM International) | Option Ex | 1,315 | 48.29 | 63,501 |
| 2019-02-26 | Kingma Todd W (Executive VP, General Counsel) | Option Ex | 1,935 | 48.29 | 93,441 |
| 2018-11-14 | Cohen Gary M | Option Ex | 3,053 | 39.62 | 120,959 |
| 2018-11-13 | Samuels Theodore R. Ii | Buy | 3,500 | 65.40 | 228,903 |
| 2018-11-12 | Parker Geoffrey M. | Buy | 3,000 | 65.35 | 196,058 |
| 2018-11-09 | Andersen Svend (EVP & President CHCI) | Buy | 3,900 | 63.01 | 245,739 |
| 2018-11-09 | Kingma Todd W (Executive VP, General Counsel) | Buy | 3,200 | 63.99 | 204,768 |
| 2018-11-09 | Kessler Murray S (CEO) | Buy | 15,683 | 63.83 | 1,001,061 |
| 2018-08-14 | Andersen Svend (EVP & President CHCI) | Buy | 7,200 | 69.43 | 499,896 |
| 2018-07-23 | Winowiecki Ronald (CFO) | Option Ex | 2,297 | 75.97 | 174,503 |
| 2018-06-29 | Winowiecki Ronald (CFO) | Option Ex | 818 | 72.91 | 59,640 |
| 2018-06-29 | Wesolowski John (EVP, President Rx) | Option Ex | 481 | 72.91 | 35,069 |
| 2018-06-29 | Weninger Paul (EVP, Quality Operations) | Option Ex | 732 | 72.91 | 53,370 |
| 2018-06-29 | Janish Ronald Craig (EVP, Global Op. & Supply Chain) | Option Ex | 827 | 72.91 | 60,296 |
| 2018-06-29 | Quinn Grainne (EVP, Chief Medical Officer) | Option Ex | 262 | 72.91 | 19,102 |
| 2018-06-06 | Samuels Theodore R. Ii | Option Ex | 4,265 | 73.22 | 312,283 |
| 2018-06-06 | O'connor Donal | Option Ex | 4,265 | 73.22 | 312,283 |
| 2018-06-06 | Karaboutis Adriana | Option Ex | 4,265 | 73.22 | 312,283 |
| 2018-06-06 | Parker Geoffrey M. | Option Ex | 4,265 | 73.22 | 312,283 |
| 2018-06-06 | Alford Bradley A | Option Ex | 4,265 | 73.22 | 312,283 |
| 2018-06-06 | Smith Jeffrey C | Option Ex | 4,265 | 73.22 | 312,283 |
| 2018-06-06 | Brlas Laurie | Option Ex | 5,331 | 73.22 | 390,335 |
| 2018-06-06 | Cohen Gary M | Option Ex | 4,265 | 73.22 | 312,283 |
| 2018-06-06 | Kindler Jeffrey B | Option Ex | 4,265 | 73.22 | 312,283 |
| 2018-06-06 | Classon Rolf A | Option Ex | 4,265 | 73.22 | 312,283 |
| 2018-05-17 | Smith Jeffrey C | Buy | 50,000 | 75.89 | 3,794,650 |
| 2018-05-16 | Smith Jeffrey C | Buy | 100,000 | 75.83 | 7,582,599 |
| 2018-05-15 | Smith Jeffrey C | Buy | 250,000 | 75.23 | 18,808,750 |
| 2018-03-05 | Roehrhoff Uwe (CEO) | Buy | 7,500 | 81.98 | 614,880 |
| 2018-03-01 | Winowiecki Ronald (Interim CFO) | Option Ex | 1,776 | 79.57 | 141,316 |
| 2018-03-01 | Wesolowski John (EVP, President Rx) | Option Ex | 1,033 | 79.57 | 82,195 |
| 2017-12-28 | Kingma Todd W (Executive VP, General Counsel) | Sale | 1,500 | 88.52 | 132,780 |
| 2017-12-28 | Kingma Todd W (Executive VP, General Counsel) | Option Ex | 2,571 | 87.27 | 224,371 |
| 2017-12-22 | Winowiecki Ronald (Interim CFO) | Option Ex | 846 | 87.01 | 73,610 |
| 2017-12-15 | Wesolowski John (EVP, President Rx) | Option Ex | 324 | 86.50 | 28,026 |
| 2017-12-14 | Wesolowski John (EVP, President Rx) | Buy | 700 | 85.80 | 60,060 |
| 2017-12-07 | Wesolowski John (EVP, President Rx) | Sale | 450 | 83.09 | 37,390 |
| 2017-11-29 | Wesolowski John (EVP, President Rx) | Sale | 168 | 87.65 | 14,725 |
| 2017-11-28 | Wesolowski John (EVP, President Rx) | Sale | 220 | 86.86 | 19,109 |
| 2017-11-16 | Farrington Thomas (EVP and CIO) | Sale | 213 | 87.25 | 18,585 |
| 2017-11-03 | Farrington Thomas (EVP and CIO) | Option Ex | 623 | 82.36 | 51,310 |
Insider trading activities including stock purchases, stock sales, and option exercises of PRGO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Perrigo Co Plc (symbol PRGO, CIK number 1585364) see the Securities and Exchange Commission (SEC) website.